- Levacetylleucine, sold
under the
brand name
Aqneursa, is a
medication used for the
treatment of
neurological manifestations of Niemann-Pick
disease type...
- vertigo) and N-acetyl-L-leucine (levacetylleucine, sold
under the
brand name
Aqneursa, and used for the
treatment of
neurological manifestations of Niemann-Pick...
- Austin,
Texas which developed levacetylleucine,
commercially known as
AQNEURSA, for the
treatment of
neurological manifestations of Niemann-Pick Disease...
- first-in-class medication. Levacetylleucine, sold
under the
brand name
Aqneursa, is a
medication used for the
treatment of
neurological manifestations...
-
approved by the FDA to
treat Niemann-Pick Disease, Type C.
Levacetylleucine (
Aqneursa) was
approved for
medical use in the
United States in
September 2024. Levacetylleucine...
- V | W | X | Y | Z Aa–Ab | Ac | Ad–Ak | Al | Am | An–Ap | Aq–Ar | As–Az
Aqneursa Aqua Lube Plus
Aquacare Aquacort Aquamephyton Aquaphyllin Aquasol A Aquatag...
-
IntraBio and her
translational work has
continued as the
companies lead drug
Aqneursa was FDA
approved in
September 2024 for the
treatment of Niemann-Pick disease...
